Found: 175
Select item for more details and to access through your institution.
The glue degraders.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 4, p. 546, doi. 10.1038/s41587-024-02164-9
- By:
- Publication type:
- Article
Drugging RNA.
- Published in:
- Nature Biotechnology, 2023, v. 41, n. 6, p. 745, doi. 10.1038/s41587-023-01790-z
- By:
- Publication type:
- Article
The lysosomal degraders.
- Published in:
- Nature Biotechnology, 2022, v. 40, n. 12, p. 1709, doi. 10.1038/s41587-022-01594-7
- By:
- Publication type:
- Article
Nature Biotechnology's academic spinouts 2021.
- Published in:
- Nature Biotechnology, 2022, v. 40, n. 11, p. 1551, doi. 10.1038/s41587-022-01530-9
- By:
- Publication type:
- Article
Erratum: Nature Biotechnology's academic spinouts of 2017.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
The PROTAC gold rush.
- Published in:
- Nature Biotechnology, 2022, v. 40, n. 1, p. 12, doi. 10.1038/s41587-021-01173-2
- By:
- Publication type:
- Article
Nature Biotechnology's academic spinouts 2020.
- Published in:
- Nature Biotechnology, 2021, v. 39, n. 9, p. 1036, doi. 10.1038/s41587-021-01043-x
- By:
- Publication type:
- Article
Hunt for improved monoclonals against coronavirus gathers pace.
- Published in:
- Nature Biotechnology, 2021, v. 39, n. 1, p. 9, doi. 10.1038/s41587-020-00791-6
- By:
- Publication type:
- Article
Publisher Correction: Histone-writer cancer drugs enter center stage.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Histone-writer cancer drugs enter center stage.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 8, p. 909, doi. 10.1038/s41587-020-0621-1
- By:
- Publication type:
- Article
Nature Biotechnology's academic spinouts of 2019.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 5, p. 546, doi. 10.1038/s41587-020-0506-3
- By:
- Publication type:
- Article
Publisher Correction: γδ T cells bring unconventional cancer-targeting to the clinic — again.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
γδ T cells bring unconventional cancer-targeting to the clinic — again.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 4, p. 389, doi. 10.1038/s41587-020-0487-2
- By:
- Publication type:
- Article
Nature Biotechnology's academic spinouts of 2018.
- Published in:
- Nature Biotechnology, 2019, v. 37, n. 6, p. 601, doi. 10.1038/s41587-019-0139-6
- By:
- Publication type:
- Article
The new liver epidemic.
- Published in:
- Nature Biotechnology, 2019, v. 37, n. 3, p. 209, doi. 10.1038/s41587-019-0047-9
- By:
- Publication type:
- Article
No added sugar: antibody makers find an upside to 'no fucose'.
- Published in:
- Nature Biotechnology, 2018, v. 36, n. 11, p. 1025, doi. 10.1038/nbt1118-1025
- By:
- Publication type:
- Article
Alnylam launches era of RNAi drugs.
- Published in:
- Nature Biotechnology, 2018, v. 36, n. 10, p. 777, doi. 10.1038/nbt0918-777
- By:
- Publication type:
- Article
Alnylam launches era of RNAi drugs.
- Published in:
- Nature Biotechnology, 2018, v. 36, n. 9, p. 777, doi. 10.1038/nbt0918-777
- By:
- Publication type:
- Article
Erratum: Nature Biotechnology's academic spinouts of 2017.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Cytokine resurrection: engineered IL-2 ramps up immuno-oncology responses.
- Published in:
- Nature Biotechnology, 2018, v. 36, n. 5, p. 378, doi. 10.1038/nbt0518-378
- By:
- Publication type:
- Article
Nature Biotechnology's academic spinouts of 2017.
- Published in:
- Nature Biotechnology, 2018, v. 36, n. 4, p. 297, doi. 10.1038/nbt.4121
- By:
- Publication type:
- Article
Driving T-cell immunotherapy to solid tumors.
- Published in:
- Nature Biotechnology, 2018, v. 36, n. 3, p. 215, doi. 10.1038/nbt.4090
- By:
- Publication type:
- Article
First metabolic oncology inhibitor gets FDA green light, with record price tag.
- Published in:
- Nature Biotechnology, 2017, v. 35, n. 10, p. 895, doi. 10.1038/nbt1017-895
- By:
- Publication type:
- Article
Adenosine checkpoint agent blazes a trail, joins immunotherapy roster.
- Published in:
- Nature Biotechnology, 2017, v. 35, n. 9, p. 805, doi. 10.1038/nbt0917-805
- By:
- Publication type:
- Article
Industry 'road tests' new wave of immune checkpoints.
- Published in:
- Nature Biotechnology, 2017, v. 35, n. 6, p. 487, doi. 10.1038/nbt0617-487
- By:
- Publication type:
- Article
Erratum: Drugging the gut microbiome.
- Published in:
- Nature Biotechnology, 2017, v. 35, n. 5, p. 481, doi. 10.1038/nbt0517-481b
- By:
- Publication type:
- Article
Oncologists await historic first: a pan-tumor predictive marker, for immunotherapy.
- Published in:
- Nature Biotechnology, 2017, v. 35, n. 4, p. 297, doi. 10.1038/nbt0417-297a
- By:
- Publication type:
- Article
Worth the RISC?
- Published in:
- Nature Biotechnology, 2017, v. 35, n. 3, p. 198, doi. 10.1038/nbt.3810
- By:
- Publication type:
- Article
Alnylam terminates revusiran program, stock plunges.
- Published in:
- Nature Biotechnology, 2016, v. 34, n. 12, p. 1213, doi. 10.1038/nbt1216-1213
- By:
- Publication type:
- Article
Big win possible for Ionis/Biogen antisense drug in muscular atrophy.
- Published in:
- Nature Biotechnology, 2016, v. 34, n. 10, p. 1002, doi. 10.1038/nbt1016-1002
- By:
- Publication type:
- Article
SALIVA: THE NEXT FRONTIER IN CANCER DIAGNOSTICS.
- Published in:
- Clinical Laboratory News, 2016, v. 42, n. 9, p. 16
- By:
- Publication type:
- Article
Cancer anabolic metabolism inhibitors move into clinic.
- Published in:
- Nature Biotechnology, 2016, v. 34, n. 8, p. 794, doi. 10.1038/nbt0816-794
- By:
- Publication type:
- Article
Erratum: No longer going to waste.
- Published in:
- Nature Biotechnology, 2016, v. 34, n. 8, p. 888, doi. 10.1038/nbt0816-888b
- By:
- Publication type:
- Article
THE PERILS AND PROMISE OF PRECISION MEDICINE.
- Published in:
- Clinical Laboratory News, 2016, v. 42, n. 7, p. 12
- By:
- Publication type:
- Article
Bristol-Myers Squibb locks into novel autoimmune strategy.
- Published in:
- Nature Biotechnology, 2016, v. 34, n. 6, p. 577, doi. 10.1038/nbt0616-577
- By:
- Publication type:
- Article
No longer going to waste.
- Published in:
- Nature Biotechnology, 2016, v. 34, n. 5, p. 458, doi. 10.1038/nbt.3557
- By:
- Publication type:
- Article
Natural killer cells blaze into immuno-oncology.
- Published in:
- Nature Biotechnology, 2016, v. 34, n. 3, p. 219, doi. 10.1038/nbt0316-219
- By:
- Publication type:
- Article
Predictive biomarkers for checkpoints, first tests approved.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 12, p. 1217, doi. 10.1038/nbt1215-1217
- By:
- Publication type:
- Article
Tumor macrophage target fuels $1.7-billion deal.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 12, p. 1222, doi. 10.1038/nbt1215-1222
- By:
- Publication type:
- Article
RIKEN suspends first clinical trial involving induced pluripotent stem cells.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 9, p. 890, doi. 10.1038/nbt0915-890
- By:
- Publication type:
- Article
A β-lactamase inhibitor revival provides new hope for old antibiotics.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 7, p. 445, doi. 10.1038/nrd4666
- By:
- Publication type:
- Article
Alnylam's RNAi therapy targets amyloid disease.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 6, p. 577, doi. 10.1038/nbt0615-577a
- By:
- Publication type:
- Article
Drugging the gut microbiome.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 3, p. 228, doi. 10.1038/nbt.3161
- By:
- Publication type:
- Article
Oncologists Push Beyond New Lung Cancer Genomic Testing Guidelines.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 2, p. 1, doi. 10.1093/jnci/djv023
- By:
- Publication type:
- Article
Promising Early Results for Immunotherapy-Antiangiogenesis Combination.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 11, p. 2, doi. 10.1093/jnci/dju392
- By:
- Publication type:
- Article
Bispecific antibodies rise again.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 11, p. 799, doi. 10.1038/nrd4478
- By:
- Publication type:
- Article
Between disease and a dish.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 8, p. 712, doi. 10.1038/nbt.2977
- By:
- Publication type:
- Article
MET inhibitors start on road to recovery.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 8, p. 563, doi. 10.1038/nrd4406
- By:
- Publication type:
- Article
Immunology: A tolerant approach.
- Published in:
- Nature, 2014, v. 507, n. 7493, p. 418, doi. 10.1038/507418a
- By:
- Publication type:
- Article
Kinase inhibitors overachieve in CLL.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 3, p. 162, doi. 10.1038/nrd4259
- By:
- Publication type:
- Article